StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

RGNXBullishAnalyst Target Updateanalyst
High materiality8/10

Regenxbio Inc. (RGNX) PT Raised to $18 at Leerink

Jun 22, 2026, 2:02 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

Leerink raises RGNX PT to $18; current price $8.88; priceChangeSinceSignal 4.95.

  • Leerink raises RGNX PT to $18; price $8.88 (+4.95).

Key facts

  1. 01

    Target: $18

  2. 02

    Posted price: $8.88

  3. 03

    Analyst firm: Leerink Partners

  4. 04

    Analyst: Mani Foroohar

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.